Stacey GandlerBrand Nourishment
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
Bud BilanichSuccess Coach
Matt TurnerPatient Affordability
Matthew DurhamOmnidynamic Marketing
Joey CohenMedication Adherence
Liz KaneImpactful Strategy
Amy GilesIncreasing Engagement
David LinetskyPoint-of-Care Marketing
Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
Paul TheisenPatient Acquisition
ZEJULA is the #1 PARP inhibitor for women with ovarian cancer in the U.S.2017 ...
CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email